Skip to main content
Friday, November 13, 2026Nov 13

TennCare seeks $975M in additional funding tied to medical costs, price of new obesity drugs

The injectable drug Ozempic is shown July 1, 2023, in Houston. Demand for semiglutide drugs like Ozempic, which is used to treat heart disease, diabetes and obesity, is a factor in TennCare's request for a budget boost. (AP Photo/David J. Phillip, File)
The injectable drug Ozempic is shown July 1, 2023, in Houston. Demand for semiglutide drugs like Ozempic, which is used to treat heart disease, diabetes and obesity, is a factor in TennCare's request for a budget boost. (AP Photo/David J. Phillip, File) The injectable drug Ozempic is shown July 1, 2023, in Houston. Demand for semiglutide drugs like Ozempic, which is used to treat heart disease, diabetes and obesity, is a factor in TennCare's request for a budget boost. (AP Photo/David J. Phillip, File)

TennCare – the state Medicaid program that pays the medical bills of 1.4 million low-income Tennesseans – is seeking a $975 million budget boost next year driven in large part by rising medical costs.

The two biggest drivers of the expected costs are an estimated $165 million in price hikes for medical care and $41 million tied to the high price tag of new classes of drugs used to treat obesity, heart disease and diabetes – drugs such as Ozempic.

This year’s budget request follows steep cuts in TennCare enrollment: 300,000 people lost coverage last year in an error-ridden process that violated the rights of thousands of Tennesseans and ran afoul of the Constitution, Medicaid law and protections for people with disabilities, a federal judge ruled in August.

It also follows the announcement by Gov. Bill Lee that $100 million in TennCare funding will be distributed in the form of no-interest loans to East Tennessee counties that suffered extensive hurricane damage in September.

(READ MORE: Federal court: TennCare illegally terminated health coverage for thousands)